Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-006513
Filing Date
2025-03-06
Accepted
2025-03-06 19:07:09
Documents
2
Period of Report
2025-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1931
2 mnpr20250306_sec16.htm EX-24 3585
  Complete submission text file 0001437749-25-006513.txt   6898
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1762 BEACON STREET BROOKLINE MA 02445
Business Address
Talukdar Lavina (Reporting) CIK: 0002059193 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39070 | Film No.: 25716858